AU2001255234A1 - Cellular calcium responce for diagnosis of alzheimer's disease - Google Patents
Cellular calcium responce for diagnosis of alzheimer's diseaseInfo
- Publication number
- AU2001255234A1 AU2001255234A1 AU2001255234A AU5523401A AU2001255234A1 AU 2001255234 A1 AU2001255234 A1 AU 2001255234A1 AU 2001255234 A AU2001255234 A AU 2001255234A AU 5523401 A AU5523401 A AU 5523401A AU 2001255234 A1 AU2001255234 A1 AU 2001255234A1
- Authority
- AU
- Australia
- Prior art keywords
- responce
- alzheimer
- diagnosis
- disease
- cellular calcium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 208000024827 Alzheimer disease Diseases 0.000 title 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 title 1
- 229910052791 calcium Inorganic materials 0.000 title 1
- 239000011575 calcium Substances 0.000 title 1
- 230000001413 cellular effect Effects 0.000 title 1
- 238000003745 diagnosis Methods 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2821—Alzheimer
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19462600P | 2000-04-05 | 2000-04-05 | |
| US60/194,626 | 2000-04-05 | ||
| PCT/US2001/011060 WO2001077686A2 (fr) | 2000-04-05 | 2001-04-05 | Coefficient de reponse cellulaire au calcium pour le diagnostic et le pronostic de la maladie d'alzheimer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001255234A1 true AU2001255234A1 (en) | 2001-10-23 |
Family
ID=22718298
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001255234A Abandoned AU2001255234A1 (en) | 2000-04-05 | 2001-04-05 | Cellular calcium responce for diagnosis of alzheimer's disease |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2001255234A1 (fr) |
| WO (1) | WO2001077686A2 (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5598200B2 (ja) | 2010-09-16 | 2014-10-01 | ソニー株式会社 | データ処理装置、データ処理方法、およびプログラム |
| CN116469540B (zh) * | 2023-03-30 | 2023-11-14 | 北京透彻未来科技有限公司 | 基于双阈值的去噪方法及系统 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6107050A (en) * | 1993-05-03 | 2000-08-22 | The United States Of America As Represented By The Department Of Health And Human Services | Diagnostic test for alzheimers disease |
| US5976816A (en) * | 1993-05-03 | 1999-11-02 | The United States Of America As Represented By The Department Of Health And Human Services | Cell tests for alzheimer's disease |
| US5580748A (en) * | 1993-05-03 | 1996-12-03 | The United States Of America As Represented By The Department Of Health And Human Services | Diagnostic tests for alzheimers disease |
| WO1999024830A1 (fr) * | 1997-11-10 | 1999-05-20 | Bristol-Myers Squibb Company | Procede pour diagnostiquer la maladie d'alzheimer |
-
2001
- 2001-04-05 AU AU2001255234A patent/AU2001255234A1/en not_active Abandoned
- 2001-04-05 WO PCT/US2001/011060 patent/WO2001077686A2/fr not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001077686A2 (fr) | 2001-10-18 |
| WO2001077686A3 (fr) | 2002-08-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001273132A1 (en) | Compounds to treat alzheimer's disease | |
| EE200200716A (et) | Ühendid Alzheimeri tõve käitluseks | |
| AU2001233299A1 (en) | Methods for treating alzheimer's disease | |
| AU2001284646A1 (en) | Quinuclidine-substituted heteroaryl moieties for treatment of disease | |
| AU2002219824A1 (en) | Compositions and methods for diagnosing alzheimer's disease | |
| IL188506A0 (en) | Use of an immunogen for preparation of pharmaceutical composition for treating alzheimer's disease | |
| HUP0301020A3 (en) | Early diagnosis of conformational diseases | |
| AU2610901A (en) | Predictive diagnostic for alzheimer's disease | |
| AU2001236592A1 (en) | Methods for diagnosis of alzheimer's disease | |
| AU2002315131A1 (en) | Aminediols as agents for the treatment of alzheimer's disease | |
| AU3173301A (en) | Methods and compositions for treatment of alzheimer's disease by enhancing plasmin or plasmin-like activity | |
| AU2001273661A1 (en) | Methods of screening for alzheimer's disease | |
| AU2002335794A1 (en) | Allylamides useful in the treatment of alzheimer's disease | |
| AU2001264950A1 (en) | Methods of screening for parkinson's disease | |
| AU2002212471A1 (en) | Peptides for use in the treatment of alzheimer's disease | |
| AU2002222108A1 (en) | Diagnosis and treatment of alzheimer's disease | |
| AU2003273310A1 (en) | Substituted aminoethers for the treatment of alzheimer's disease | |
| IL141950A0 (en) | Diagnosis of prion diseases | |
| AU2001255234A1 (en) | Cellular calcium responce for diagnosis of alzheimer's disease | |
| AUPR202400A0 (en) | Method of screening for inhibitors of alzheimer's disease | |
| AU2003299101A1 (en) | Compounds for the treatment of alzheimer's disease | |
| AU2001267826A1 (en) | Remedies for alzheimer's disease | |
| HUP0103149A3 (en) | Pharmaceutical composition for treatment of alzheimer's disease | |
| AU2001253219A1 (en) | Composition for treatment of autoimmune disease | |
| AU2001258569A1 (en) | Alzheimer's disease assay |